The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Clozapine‐induced myocarditis, a widely overlooked adverse reaction
Abstract
Objective: We review the published cases of clozapine‐induced myocarditis and describe reasons for the higher incidence in Australia (>1%) than elsewhere (<0.1%). Method: Medline was searched to September 2014 using ‘clozapine’ as the sole term. Results: A total of around 250 cases of clozapine‐induced myocarditis have been published. Fever among patients commencing clozapine has been reported internationally, and very few of these cases were investigated for myocarditis. The time to onset of fever is consistent with its being part of a prodrome of undiagnosed myocarditis, and the risk factors are similar to those for myocarditis. In more severe cases, clozapine is discontinued, avoiding fatalities which may occur with myocarditis. Furthermore, cases of sudden death and respiratory illness may well have been undiagnosed myocarditis. The diagnosis of myocarditis is confounded by the non‐specific nature of the signs and symptoms, and it depends on appropriate investigations being conducted at the time of myocardial involvement or, for fatal cases, the affected area of the myocardium being sampled for histology. Conclusion: It is likely that the incidence of myocarditis is around 3%. Implementation of monitoring procedures will increase case ascertainment and result in more patients benefiting from this valuable medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Feldman, A. M., & McNamara, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 958
Medical Comorbidity in Schizophrenia
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.413 · Cited by 624
Myocarditis and cardiomyopathy associated with clozapine
Kilian, J. G., Kerr, K., Lawrence, C., & Celermajer, D. S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10385-4 · Cited by 544
Schizophrenia, neuroleptic medication and mortality
Joukamaa, M., Heliövaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.2.122 · Cited by 395
Mortality in Current and Former Users of Clozapine
Walker, A. M., Lanza, L. L., Arellano, F., & Rothman, K. J. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00010 · Cited by 328
Povlsen, U. J., Norrng, U., Fog, R., & Gerlach, J. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb01268.x · Cited by 278
Lindström, L. H. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb05164.x · Cited by 246
Mortality in Current and Former Users of Clozapine
Walker, A. M., Lanza, L. L., Arellano, F., & Rothman, K. J. (1997) · Epidemiology · doi:10.1097/00001648-199711000-00014 · Cited by 239
Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study
Coulter, D. M., Bate, A., Meyboom, R. H. B., Lindquist, M., & Edwards, I. R. (2001) · BMJ · doi:10.1136/bmj.322.7296.1207 · Cited by 234
Ronaldson, K. J., Fitzgerald, P. B., Taylor, A. J., Topliss, D. J., & McNeil, J. J. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.572852 · Cited by 230
Self-citationAdverse Cardiac Effects Associated With Clozapine
Merrill, D. B., Dec, G. W., & Goff, D. C. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150217.51433.9f · Cited by 200
Haas, S. J., Hill, R., Krum, H., Liew, D., Tonkin, A., Demos, L., Stephan, K., & McNeil, J. (2007) · Drug Safety · doi:10.2165/00002018-200730010-00005 · Cited by 197
Self-citationRonaldson, K. J., Fitzgerald, P. B., Taylor, A. J., Topliss, D. J., Wolfe, R., & McNeil, J. J. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.08.018 · Cited by 165
Self-citationMyocarditis and Cardiomyopathy Associated with Clozapine Use in the United States
Grenade, L. L., Graham, D., & Trontell, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450317 · Cited by 161
Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia
Kuo, C., Yang, S.-Y., Liao, Y., Chen, W. J., Lee, W., Shau, W., Chang, Y.-T., Tsai, S., & Chen, C. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr202 · Cited by 157
Ronaldson, K. J., Taylor, A. J., Fitzgerald, P. B., Topliss, D. J., Elsik, M., & McNeil, J. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05024yel · Cited by 149
Self-citationMyocarditis Related to Clozapine Treatment
Hägg, S., Spigset, O., BAHons, A. B., & Söderström, T. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00005 · Cited by 140
Taylor, D. M., Douglas-Hall, P., Olofinjana, B., Whiskey, E., & Thomas, A. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.051979 · Cited by 99
Ronaldson, K. J., Fitzgerald, P. B., Taylor, A. J., Topliss, D. J., & McNeil, J. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.01.017 · Cited by 98
Self-citationClozapine-Related Myocarditis and Cardiomyopathy in an Australian Metropolitan Psychiatric Service
Reinders, J., Parsonage, W. A., Lange, D., Potter, J. M., & Plever, S. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01481.x · Cited by 96
Myocarditis During Clozapine Treatment
Merrill, D. B., Ahmari, S. E., Bradford, J.-M. E., & Lieberman, J. A. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.204 · Cited by 95
Gaertner, H., Fischer, E., & Hoss, J. (1989) · Psychopharmacology · doi:10.1007/bf00442570 · Cited by 86
Clozapine for the treatment of schizophrenia
Fakra, É., & Azorin, J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.709235 · Cited by 82
Update on the Adverse Effects of Clozapine: Focus on Myocarditis
Berardis, D. D., Serroni, N., Campanella, D., Olivieri, L., Ferri, F., Carano, A., Cavuto, M., Martinotti, G., Cicconetti, A., Piersanti, M., et al. (2012) · Current Drug Safety · doi:10.2174/157488612800492681 · Cited by 79
Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine
Wehmeier, P. M., Heiser, P., & Remschmidt, H. (2005) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2004.00616_1.x · Cited by 70
The Choice of Antipsychotic Drugs for Schizophrenia
Freedman, R. (2005) · New England Journal of Medicine · doi:10.1056/nejme058200 · Cited by 68
Reason for clozapine cessation
Pai, N. B., & Vella, S. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01776.x · Cited by 63
Clozapine-Induced Hypersensitivity Myocarditis
Pieroni, M., Cavallaro, R., Chimenti, C., Smeraldi, E., & Frustaci, A. (2004) · CHEST Journal · doi:10.1378/chest.126.5.1703 · Cited by 62
Suspected clozapine poisoning in the UK/Eire, 1992–2003
Flanagan, R. J., Spencer, E. P., Morgan, P. E., Barnes, T. R. E., & Dunk, L. P. (2004) · Forensic Science International · doi:10.1016/j.forsciint.2004.10.024 · Cited by 57
Antipsychotic clozapine (Clozaril): myocarditis and cardiovascular toxicity.
Wooltorton, E. (2002) · PubMed Central · Cited by 51
Clozapine-Induced Fevers and 1-Year Clozapine Discontinuation Rate
Tham, J. C., & Dickson, R. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1005 · Cited by 51
Early Recognition of Clozapine-Induced Myocarditis
Annamraju, S., Sheitman, B., Peebles, S. S., & Stephenson, A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31814e5e68 · Cited by 49
Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience
Murch, S., Tran, N., Liew, D., Petrakis, M., Prior, D., & Castle, D. J. (2013) · Australasian Psychiatry · doi:10.1177/1039856213475684 · Cited by 45
Myocarditis Associated with Clozapine Treatment
Degner, D., Bleich, S., Grohmann, R., Bandelow, B., & Rüther, E. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2000.0822n.x · Cited by 41
Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment
Fineschi, V., Neri, M., Riezzo, I., et al. (2004) · International Journal of Legal Medicine · doi:10.1007/s00414-004-0464-1 · Cited by 40
Hill, G. R., & Harrison‐Woolrych, M. (2008) · PubMed · Cited by 34
Wehmeier, P. M., Schüler-Springorum, M., Heiser, P., et al. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041648977 · Cited by 30
Kelly, D. L., Wehring, H. J., Linthicum, J., Feldman, S. M., McMahon, R. P., Love, R. C., Wagner, T., Shim, J. C., & Fowler, D. R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.10.020 · Cited by 30
Chow, V., Feijo, I., Trieu, J., Starling, J., & Kritharides, L. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0098 · Cited by 28
Schizophrenia as a Cause of Death
Rosh, A., Sampson, B. A., & Hirsch, C. S. (2003) · Journal of Forensic Sciences · doi:10.1520/jfs2002001 · Cited by 27
Clozapine Induced Myopericarditis
Razminia, M., Salem, Y., Sivasubramaniam, D., Shah, N., & Khosla, S. (2006) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000212704.79248.3d · Cited by 26
The characteristics of clozapine-induced fever
Jeong, S.-H., Ahn, Y.-M., Koo, Y.-J., et al. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00262-6 · Cited by 24
Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives
Lang, U. E., Wilbring, M., von Golitschek, R., Schmeißer, A., Matschke, K., & Tugtekin, S. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107082136 · Cited by 24
Clozapine-Induced Myocarditis: Is Mandatory Monitoring Warranted for Its Early Recognition?
Munshi, T. A., Volochniouk, D., Hassan, T., & Mazhar, N. (2014) · Case Reports in Psychiatry · doi:10.1155/2014/513108 · Cited by 19
Igeta, H., Suzuki, Y., Motegi, T., Sasaki, A., Yokoyama, Y., & Someya, T. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.04.007 · Cited by 19
Acute Myocarditis Associated with Clozapine
Varambally, S. S., & Howpage, P. (2007) · Australasian Psychiatry · doi:10.1080/10398560701348601 · Cited by 13
Management of Clozapine-Induced Fever in a Child
Driver, D. I., Anvari, A. A., Peroutka, C. M., Kataria, R., Overman, J., Lang, D., Tietcheu, M., Parker, R., Baptiste, K., Rapoport, J. L., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070866 · Cited by 7
Cited by
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
International trends in clozapine use: a study in 17 countries
Bachmann, C. J., Aagaard, L., Bernardo, M., Brandt, L., Cartabia, M., Clavenna, A., Coma Fusté, A., Furu, K., Garuoliené, K., Hoffmann, F., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12742 · Cited by 314
An update of safety of clinically used atypical antipsychotics
Orsolini, L., Tomasetti, C., Valchera, A., Vecchiotti, R., Matarazzo, I., Vellante, F., Iasevoli, F., Buonaguro, E. F., Fornaro, M., Fiengo, A. L. C., et al. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1201475 · Cited by 135
Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
Yuen, J. W. Y., Kim, D. D., Procyshyn, R. M., White, R. F., Honer, W. G., & Barr, A. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00203 · Cited by 79
Rohde, C., Polcwiartek, C., Kragholm, K., Ebdrup, B. H., Siskind, D., & Nielsen, J. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12827 · Cited by 71
Metadata
- Authors
- Ronaldson, K. J., Fitzgerald, P. B., & McNeil, J. J.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2015-04-11
- Volume
- 132
- Issue
- 4
- Pages
- 231-240
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W1979668217
- Cited by
- 314
- References
- 50
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.